274 related articles for article (PubMed ID: 30184027)
1. Predictive Value of Mean Platelet Volume in Saphenous Vein Graft Disease.
Kaya U; Koza Y
Braz J Cardiovasc Surg; 2018; 33(4):317-322. PubMed ID: 30184027
[TBL] [Abstract][Full Text] [Related]
2. Association Between Platelet to Lymphocyte Ratio and Saphenous Vein Graft Disease.
Yayla Ç; Canpolat U; Akyel A; Yayla KG; Yilmaz S; Açikgöz SK; Özcan F; Turak O; Doğan M; Yeter E; Aydoğdu S
Angiology; 2016 Feb; 67(2):133-8. PubMed ID: 25818104
[TBL] [Abstract][Full Text] [Related]
3. Plateletcrit. A platelet marker associated with saphenous vein graft disease.
Akpinar I; Sayin MR; Gursoy YC; Karabag T; Kucuk E; Buyukuysal MC; Aydin M; Haznedaroglu IC
Herz; 2014 Feb; 39(1):142-8. PubMed ID: 23575980
[TBL] [Abstract][Full Text] [Related]
4. Relationship between elevated platelet volume and saphenous vein graft disease.
Tavil Y; Sen N; Yazici HU; Hizal F; Açikgöz SK; Turfan M; Cengel A
Clin Invest Med; 2010 Jun; 33(3):E161-7. PubMed ID: 20519094
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Serum Albumin Level and Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with Saphenous Vein Graft Disease in Coronary Bypass.
Akboga MK; Yayla C; Balci KG; Ozeke O; Maden O; Kisacik H; Temizhan A; Aydogdu S
Thorac Cardiovasc Surg; 2017 Jun; 65(4):315-321. PubMed ID: 27111497
[No Abstract] [Full Text] [Related]
6. Red blood cell distribution width in saphenous vein graft disease.
Akyel A; Celik IE; Oksüz F; Cay S; Karadeniz M; Kurtul A; Ocek AH; Murat SN
Can J Cardiol; 2013 Apr; 29(4):448-51. PubMed ID: 22926040
[TBL] [Abstract][Full Text] [Related]
7. Association between plasma asymmetrical dimethylarginine activity and saphenous vein graft disease in patients with coronary bypass.
Cagirci G; Cay S; Karakurt O; Buyukterzi Z; Yazihan N; Kilic H; Topaloglu S; Aras D; Akdemir R
Coron Artery Dis; 2010 Jan; 21(1):20-5. PubMed ID: 19996737
[TBL] [Abstract][Full Text] [Related]
8. Relationship between neutrophil-to-lymphocyte ratio and saphenous vein graft disease in patients with coronary bypass.
Doğan M; Akyel A; Cimen T; Öksüz F; Celik IE; Aytürk M; Murat SN; Yeter E
Clin Appl Thromb Hemost; 2015 Jan; 21(1):25-9. PubMed ID: 23653146
[TBL] [Abstract][Full Text] [Related]
9. High mean platelet volume to platelet count ratio as a predictor on poor outcomes after CABG.
Tüysüz ME; Dedemoğlu M
Gen Thorac Cardiovasc Surg; 2020 May; 68(5):459-466. PubMed ID: 31515731
[TBL] [Abstract][Full Text] [Related]
10. Relationship between elevated levels of serum uric acid and saphenous vein graft disease.
Tavil Y; Sen N; Hizal F; Açikgöz SK; Taşoğlu I; Topal S; Yalçin MR
Turk Kardiyol Dern Ars; 2008 Jan; 36(1):14-8. PubMed ID: 18453781
[TBL] [Abstract][Full Text] [Related]
11. Patency of the saphenous vein conduit anastomosed to the aortic dacron graft.
Kara I; Koksal C; Boyacioglu K; Ay Y; Yanartas M; Metin Esen A
J Cardiovasc Surg (Torino); 2013 Oct; 54(5):647-52. PubMed ID: 24002395
[TBL] [Abstract][Full Text] [Related]
12. The Predictive Effects of Clinical Hematological Changes on Saphenous Graft Patency after Coronary Artery Surgery.
İyigün T; Kyaruzi MM; Timur B; Satılmışoğlu MH; İyigün M; Kaya M
Braz J Cardiovasc Surg; 2019 Jun; 34(3):297-304. PubMed ID: 31310468
[TBL] [Abstract][Full Text] [Related]
13. Impact of the size mismatch between saphenous vein graft and coronary artery on graft patency.
Yamane Y; Uchida N; Okubo S; Morimoto H; Mukai S
Gen Thorac Cardiovasc Surg; 2017 Jan; 65(1):25-31. PubMed ID: 27485249
[TBL] [Abstract][Full Text] [Related]
14. Relationship between plaque composition by virtual histology intravascular ultrasound and clinical outcomes after percutaneous coronary intervention in saphenous vein graft disease patients: study protocol of a prospective cohort study.
Liu Y; Wang HB; Li X; Xiao JY; Wang JX; Reilly KH; Sun B; Gao J
BMC Cardiovasc Disord; 2018 Dec; 18(1):233. PubMed ID: 30541457
[TBL] [Abstract][Full Text] [Related]
15. C-Reactive Protein to Albumin Ratio in Patients With Saphenous Vein Graft Disease.
Yayla C; Gayretli Yayla K
Angiology; 2021 Sep; 72(8):770-775. PubMed ID: 33678042
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the Logistic Clinical Syntax Score in Prediction of Saphenous Vein Graft Failure in Patients Undergoing Coronary Artery Bypass Grafting.
Ozturk D; Celık O; Cakmak HA; Akın F; Aslan S; Enhos A; Tasbulak O; Ayca B; Erkanlı K; Bakır İ
Angiology; 2015 Sep; 66(8):714-20. PubMed ID: 25385816
[TBL] [Abstract][Full Text] [Related]
17. Preoperative neutrophil-lymphocyte ratio and saphenous vein graft patency after coronary artery bypass grafting.
Taşoğlu I; Turak O; Nazli Y; Ozcan F; Colak N; Sahin S; Kavasoglu K; Genc B; Sert D; Karahan M; Cicek O; Ecevit A
Clin Appl Thromb Hemost; 2014 Nov; 20(8):819-24. PubMed ID: 23580624
[TBL] [Abstract][Full Text] [Related]
18. The Role of Systemic Immune Inflammation Index for Predicting Saphenous Vein Graft Disease in Patients with Coronary Artery Bypass Grafting.
Dogdus M; Dindas F; Yenercag M; Yildirim A; Ozcan Abacioglu O; Kilic S; Yavuz F; Koyun E; Candan O
Angiology; 2023 Jul; 74(6):579-586. PubMed ID: 36154493
[TBL] [Abstract][Full Text] [Related]
19. Study on the correlation of modified Blalock Taussig duct occlusion and platelet parameters in congenital heart disease.
Zhu Y; Zhang Y; Liu Y; Fan X; Ding N; Li Z
Asian J Surg; 2019 May; 42(5):599-603. PubMed ID: 30340821
[TBL] [Abstract][Full Text] [Related]
20. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
Rodés-Cabau J; Jolly SS; Cairns J; Mansour S; L'Allier PL; Teefy PJ; Graham JJ; Le May MR; Cantor WJ; Wood D; Balasubramanian K; DeLarochellière R; Dzavik V;
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27815344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
